Effect of tea polyphenol on oxidative injury in S180 cells induced hepatocarcinoma mice

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 5571-5583

  Cui, Bo Kang ^a   Liu, Su ^b   Li, Shu Hong ^a   Wang, Jun ^a   Wang, Qi Bo ^a   Li, Sheng Ping ^a   Lin, Xiao Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Guangzhou Institute for Drug Control   (China)

Author keywords

Antioxidant; AST; Hepatocarcinoma; Mice; S180 cell; Tea polyphenol

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; POLYPHENOL; SUPEROXIDE DISMUTASE; TEA POLYPHENOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTIOXIDANT; TEA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; IN VIVO STUDY; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER LEVEL; LOW DRUG DOSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DRUG EFFECTS; LIVER; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TEA;

ANIMALIA; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CARCINOMA, HEPATOCELLULAR; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; POLYPHENOLS; TEA;

EID: 84861534652     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13055571     Document Type: Article

References (57)

1. Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 1971, 285, 1182-1185.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 1990, 82, 4-6.
3. Denekamp, J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 1993, 66, 181-196.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1, 27-31.
5. Fox, S.B.; Gatter, K.C.; Harris, A.L. Tumor angiogenesis. J. Pathol. 1996, 179, 232-237.
6. Chen, C.J.; Yu, M.W.; Liaw, Y.F. Epidemiological characteristic and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997, 12, S294-S308.
7. Tee, L.B.G.; Kirilak, Y.; Huang, W.; Morgan, R.H.; Yeoh, G.C.T. Differentiation of oval cell into duct-like cells in preneoplastic liver of rats placed on a choline deficient diet supplemented with ethionine. Carcinogenesis 1994, 15, 2747-2756.
8. Chandrasoma, P.; Taylor, C.R. The Liver: II. Toxic & Metabolic Diseases; Neoplasms. In Concise Pathology, 3rd ed.; McGraw-Hill Publishing Co.: New York, NY, USA, 1997; pp. 649-662.
9. Chermahini, S.H.; Majid, F.A.A.; Sarmidi, M.R.; Taghizadeh, E.; Salehnezhad, S. Impact of saffron as an anti-cancer and anti-tumor herb. Afr. J. Pharm. Pharmacol. 2010, 4, 834-840.
10. Bayramoglu, G.; Kabay, S.; Ozden, H.; Ustuner, M.C.; Uysal, O.; Bayramoglu, A.; Senturk, H.; Güven, G.; Ozbayer, C.; Kutlu A; et al. The effect of Echinacea on kidney and liver after experimental renal ischemia/reperfusion injury in the rats. Afr. J. Pharm. Pharmacol. 2011, 5, 1561-1566.
11. Trush, M.A.; Kensler, T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 1991, 10, 201-209.
12. Rice-Evans, C.; Burdon, R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 1993, 32, 71-110.
13. Hemalatha, S.; Wahi, A.K.; Singh, P.N.; Chansouria, J.P.N. Evaluation of anti-hyperglycemic and free radical scavenging activity of Melothria maderaspatana Linn. in streptozotocin-induced diabetic rats. Afr. J. Pharm. Pharmacol. 2010, 4, 823-828.
14. Saddiq, A.A.; Kalifa, S.A. Impact of fungal content of some Arabic nuts to induce kidney toxicity and agonistic action of natural resources. Afr. J. Microbiol. Res. 2011, 5, 1046-1056.
15. Ames, B.N. Dietary carcinogens and anticarcinogens: Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264.
16. Willett, W.C.; MacMahon, B. Diet and cancer-an overview. N. Engl. J. Med. 1984, 310, 633-638.
17. Karsen, H.; Karahocagil, M.K.; Akdeniz, H.; Ceylan, M.R.; Binici, I.; Selek, S.; Celik, H. Serum paraoxonase and arylesterase activities and oxidant status in patients with brucellosis. Afr. J. Microbiol. Res. 2011, 5, 1701-1706.
18. Packer, L.; Colman, C. The Antioxidant Miracle; John Wiley & Sons Inc.: Toronto, ON, Canada, 1999.
19. Halliwell, B. Free radical and metal ions in health and disease. Proc. Nutr. Soc. 1987, 46, 13-26.
20. Gupta, M.; Mazumder, U.; Kumar, T.; Gomathi, P.; Kumar, R. Antioxidant and hepatoprotective effects of Buhinia racemosa against paracetamol and carbon tetrachloride induced liver damage in rats. Iran. J. Pharm. Ther. 2004, 3, 12-20.
21. Frei, B.; Higdon, J. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr. 2003, 133, 3275-3284.
22. Marzony, E.T.; Kamali, M.; Saadati, M.; Keihan, A.H.; Fooladi, A.A.I.; Sajjadi, S. Single multiplex PCR assay to identify the shiga toxin. Afr. J. Microbiol. Res. 2011, 5, 1794-1800.
23. Mukhtar, H.; Ahmad, N. Tea polyphenols: Prevention of cancer. Am. J. Clin. Nutr. 2000, 71, 1698-1702.
24. Cao, Y.; Cao, R. Angiogenesis inhibited by drinking tea. Nature 1999, 398, doi:10.1038/18793.
25. Pfeffer, U.; Ferrari, N.; Morini, M.; Benelli, R.; Noonan, D.M.; Albini, A. Antiangiogenic activity of chemopreventive drugs. Int. J. Biol. Markers 2003, 18, 70-74.
26. Wang, Z.Y.; Cheng, S.J.; Zhou, Z.C.; Athar, M.; Khan, W.A.; Bickers, D.R.; Mukhtar, H. Antimutagenic activity of green tea polyphenols. Mutat. Res. 1989, 223, 273-285.
27. Han, C. Screening of anticarcinogenic ingredients in tea polyphenols. Cancer Lett. 1997, 114, 153-158.
28. Stapleton, P.D.; Shah, S.; Anderson, J.C.; Hara, Y.; Hamilton-Miller, J.M.; Taylor, P.W. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents 2004, 23, 462-467.
29. Nance, C.L.; Shearer, W.T. Is green tea good for HIV-1 infection? J. Allergy Clin. Immunol. 2003, 112, 851-853.
30. Esposito, E.; Rotilio, D.; di Matteo, V.; di Giulio, C.; Cacchio, M.; Algeri, S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging 2002, 23, 719-735.
31. Dona, M.; Dell'Aica, I.; Calabrese, F.; Benelli, R.; Morini, M.; Albini, A.; Garbisa, S. Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 2003, 170, 4335-4341.
32. Dong, W.; Ning, L.; Lu, W.-D.; Li, C.-C.; Chen, R.-P.; Jia, X.-N.; Wang, L.; Guo, L.-Z. Tumor-inhibitory and liver-protective effects of Phellinus igniarius extracellular polysaccharides. World J. Microbiol. Biotechnol. 2009, 25, 633-638.
33. Naik, S.R.; Panda, V.S. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int. 2007, 27, 393-399.
34. El-Beshbishy, H.A.; Tork, O.M.; El-Bab, M.F.; Autifi, M.A. Antioxidant and antiapoptotic effects of green tea polyphenols against azathioprine-induced liver injury in rats. Pathophysiology 2011, 18, 125-135.
35. Erlinger, T.P.; Muntner, P.; Helzlsouer, K.J. WBC count and the risk of cancer mortality in a national sample of US adults: Results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol. Biomark. Prev. 2004, 13, 1052-1056.
36. Nohara, T. Establishment of an AFP-producing serum-independent culture cell line of human liver cancer and changes in protein synthesis associated with the absence of serum (Second Part). J. Gastroenterol. 1988, 23, 23-28.
37. Jethwani Urmi, N.; Mulla Summaiya, A.; Shah Latika, N. Detection of inducible clindamycin resistance by an automated system in a tertiary care hospital. Afr. J. Microbiol. Res. 2011, 5, 2870-2872.
38. Adeneye, A.A.; Olagunju, J.A.; Banjo, A.A.F.; Abdul, S.F.; Sanusi, O.A.; Sanni, O.O.; Osarodion, B.A.; Shonoiki, O.E. The aqueous seed extract of Carica papaya Linn. prevents carbon tetrachloride induced hepatotoxicity in rats. Int. J. Appl. Res. Nat. Prod. 2009, 2, 19-32.
39. Khan, F.A.; Mishra, H. A comparative study of cyclo-oxygenase inhibitors on immune response with special reference to Cox-2 inhibitors. Afr. J. Pharm. Pharmacol. 2011, 5, 1633-1637.
40. Llovera, M.; López-Soriano, F.J.; Argilés, J.M. Effects of tumor necrosis factor-α on muscle-protein turnover in female wistar rats. J. Natl. Cancer Inst. 1993, 85, 1334-1339.
41. Yuksel, P.; Saribas, S.; Bagdatli, Y. Comparison of the VersaTrek and BACTEC MGIT 960 systems for the contamination rate, time of detection and recovery of mycobacteria from clinical specimens. Afr. J. Microbiol. Res. 2011, 5, 985-989.
42. Cardier, J.E.; Schulte, T.; Kammer, H.; Kwak, J.; Cardier, M. Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: Implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 1999, 13, 1950-1960.
43. Gray, P.W.; Goeddel, D.V. Structure of the human immune interferon gene. Nature 1982, 298, 859-863.
44. Hussain, S.P.; Hofseth, L.J.; Harris, C.C. Radical causes of cancer. Nat. Rev. Cancer 2003, 3, 276-285.
45. de Maria, N.; Colantoni, A.; Fagiuoli, S. Association between reactive oxygen species, disease activity in chronic hepatitis C. Free Radic. Biol. Med. 1996, 21, 291-295.
46. Rubiolo, J.A.; Mithieux, G.; Vega, F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008, 591, 66-72.
47. Das, S.; Das, D.K. Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 2007, 6, 168-173.
48. Bishayee, A.; Barnes, K.F.; Bhatia, D.; Darvesh, A.S.; Carroll, R.T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. (Phila.) 2010, 3, 753-763.
49. Draper, H.H.; Hadley, M. MDA determination as an index of lipid peroxidation. Methods Enzymol. 1990, 186, 421-430.
50. Hammouda, A.; Khalil, M.M.; Salem, A. Lipid peroxidation products in pleural fluid for separation of transudates and exudates. Clin. Chem. 1995, 41, 1314-1315.
51. Beutler, E.; Duran, O.; Kelly, B.M. Improved method for determination of blood glutathione. J. Lab. Clin. Med. 1963, 61, 882-888.
52. Minami, M.; Yoshikawa, H. A simplified assay method of superoxide dismutase activity for clinical use. Clin. Chim. Acta 1979, 92, 337-342.
53. Aebi, H. Catalase. In Methods of Enzymatic Analysis; Bergmeyer, H.U., Ed.; Academic Press: New York, NY, USA, 1974; pp. 673-684.
54. Lawrence, R.A.; Burk, R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Commun. 1976, 71, 952-958.
55. Mantha, S.V.; Prasad, M.; Kalra, J.; Prasad, K. Antioxidant enzymes in hypercholesterolemia and effects of Vitamin E in rabbits. Atherosclerosis 1993, 101, 135-144.
56. Gornall, A.G.; Bardwill, C.J.; David, M.M. Determination of serum proteins by means of biuret reaction. J. Biol. Chem. 1949, 177, 751-766.
57. Carlberg, I.; Mannervik, B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975, 250, 5475-5480.